VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
OHI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
OHIOmega Healthcare Investors, Inc.
$49.62$14.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksOHICash Flow

Omega Healthcare Investors, Inc. (OHI) Cash Flow Statement

30Y historyFree accessUpdated daily

Operational resilience is highlighted by an FFO-to-Net Income ratio of 1.43 in 2026Q1, while the dividend payout ratio relative to AFFO has improved to 0.84.

OHI Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations912.1M878.55M749.43M626.54M625.73M722.14M708.26M553.75M499.37M577.91M625.79M463.88M337.54M279.95M208.27M169.77M157.56M147.22M89.33M84.54M62.81M72.96M54.36M56.45M41.55M15.91M19.49M74.31M69.71M60.43M54.89M
Operating CF Growth %70.76%17.23%19.61%0.13%-13.35%1.96%27.9%10.89%-13.59%-7.65%34.9%37.43%20.57%34.42%22.68%7.75%7.02%64.81%5.66%34.6%-13.91%34.21%-3.7%35.88%161.16%-18.39%-73.77%6.6%15.36%10.1%22.51%
Operating CF / Revenue %73.62%73.33%71.28%65.97%71.25%67.95%79.37%59.62%56.64%63.62%69.47%62.38%66.87%66.86%59.43%58.1%61%74.57%46.1%52.99%46.35%66.54%62.51%69.53%33.84%6.65%7.4%61.19%63.77%66.55%75.06%
Net Income632.09M609.47M417.8M241.72M438.84M428.3M163.54M351.95M293.88M104.91M383.37M233.31M221.35M172.52M120.7M52.61M58.44M82.11M78.14M69.37M55.7M36.69M16.74M23.03M-14.65M-19.72M-49.56M19.67M50M44.9M34.6M
Depreciation & Amortization329.51M325.25M304.65M319.68M332.41M342.01M329.92M301.68M281.28M287.59M267.06M210.7M123.26M128.65M112.98M100.34M84.62M44.69M39.89M36.06M32.26M27.4M23.4M20.98M21.27M22.07M23.27M24.21M21.54M16.91M13.69M
Stock-Based Compensation38.97M44.19M36.7M027.3M21.41M18.82M15.36M15.99M15.21M13.79M11.13M8.59M5.94M5.94M6.04M000000000000000
Other Non-Cash Items40.2M-97.4M-42.57M80.24M-127.24M35.12M-2.55M3.67M-1.64M1.69M-14.69M10.97M4.84M-4.54M-991K-150K20.78M6.91M1.25M-17.07M-27.89M11.23M13.49M20.58M36.51M17.14M45.76M33.54M2.15M1.18M696K
Working Capital Changes15.56M-2.95M32.85M-15.1M-45.58M-94.03M-30.84M-124.06M-127.88M-89.43M-42.1M-21.44M-11.9M-16.68M-24.42M-19.83M-6.28M13.51M-29.95M-3.82M2.74M-2.36M731K-8.14M-1.59M-3.58M20K-3.11M-3.98M-2.56M5.9M
Cash from Investing-829.07M-539.79M-671.16M-9.78M442.85M-524.17M-89.06M-378.95M-173.22M-285.13M-1.11B-397.41M-547.95M-598.83M-390.7M-257.64M-394.81M-209M-187.1M-29.91M-161.35M-195.34M-106.23M31.11M30.88M29.29M31.01M-42.64M-241.61M-189.36M-94.84M
Acquisitions (Net)-14.97M-122.09M-971K-202K-113K-16.21M-10.03M-163.58M201.09M2.34M-50.03M84.86M00019.6M36.02M-23.23M-17.46M000-114.21M0000-79.84M000
Purchase of Investments000-739.92M-619.22M-164.79M-167.94M-100.31M-385.71M-139.05M-271.56M-65.4M-9.44M-36.66M-9.74M-163.55M-37.09M-44.94M-111.24M-8.98M-34.45M-9.57M-3.43M00000000
Sale of Investments38.73M4.24M8.43M750.22M759.05M111.11M149.87M91.28M181.37M95.7M96.79M45.87M13.59M30.96M15.36M12.21M21.48M42.9M48.41M9.04M2.41M60.51M6.15M12.91M000037.77M00
Other Investing-852.83M-421.94M-678.62M18.14M350.36M-359.21M14.15M-66.67M-30.54M-157.43M-820.13M-298.51M-552.09M-593.14M-396.32M-19.6M-36.02M-1.02M23.4M18.08M56.4M6.25M125.08M19.7M31.61M29.29M31.01M117.05M-121.91M-4.48M-76.22M
Cash from Financing-436.24M-838.26M26.32M-473.31M-789.45M-341.12M-485.55M-153.96M-410.7M-303.81M576.3M-65.32M212.28M319.79M183.79M81.3M242M63.74M96M-53.39M95.33M114.25M60.85M-98.81M-68.69M-40.92M-47.44M-29.45M173.27M123.18M39.78M
Dividends Paid-789.59M-780.39M-685.45M-643.87M-632.89M-637.65M-612.31M-564.13M-528.7M-502.6M-453.15M-358.23M-258.5M-218.12M-182.19M-161.89M-138.88M-109.23M-98.06M-81.26M-66.87M-55.75M-49.17M-65.47M00-29.65M-65.29M-61.17M-51.43M-42.32M
Common Dividends-591.17M-780.39M-685.45M-643.87M-632.89M-637.65M-612.31M-564.13M-528.7M-502.6M-453.15M-358.23M-258.5M-218.12M-182.19M-161.89M-138.88M-109.23M-98.06M-81.26M-66.87M-55.75M-49.17M-65.47M00-29.65M-65.29M-61.2M-51.4M-42.32M
Debt Issuance (Net)-1000K-1000K-1000K-1000K1000K1000K1000K-1000K1000K1000K1000K-1000K1000K1000K1000K1000K1000K1000K-1000K-1000K1000K1000K1000K-1000K-1000K-1000K-1000K1000K1000K1000K1000K
Share Repurchases-2.09M000-142.27M000-134K-48K-733K0000-2.93M0000-178K0-59.59M000-100M-8.11M-3.5M00
Other Financing212.59M-81.96M-36.41M62.07M-22.4M-74.3M-39.15M-25.85M21.65M-17.25M183.61M57.78M50.19M46.82M93.55M53.56M26.91M19.36M31.4M18.11M31.58M-3.05M-13.26M-7.76M32.81M-2.7M4.63M1.42M-51.1M-61.1M-33.61M
Net Change in Cash-350.75M-494.17M104M144.09M276.23M-143.15M134.18M21.71M-85.14M-10.47M88.26M935K1.87M905K1.36M-6.57M4.75M1.96M-1.77M1.25M-3.22M-8.13M8.99M-11.25M3.73M4.27M3.07M2.23M1.38M-5.74M-182K
Exchange Rate Effect3.5M5.33M-580K430K-2.9M7K527K874K-590K568K84K-223K0000000000000000000
Cash at Beginning54.56M548.74M444.73M300.64M24.41M167.56M33.38M11.67M96.81M107.28M5.42M4.49M2.62M1.71M351K6.92M2.17M209K1.98M729K3.95M12.08M3.09M14.34M11.45M7.17M4.11M1.88M500K6.24M6.43M
Cash at End53.32M54.56M548.74M444.73M300.64M24.41M167.56M33.38M11.67M96.81M93.69M5.42M4.49M2.62M1.71M351K6.92M2.17M209K1.98M729K3.95M12.08M3.09M15.18M11.45M7.17M4.11M1.88M500K6.24M
Free Cash Flow912.41M878.55M712.69M588.53M578.51M627.07M633.14M414.07M359.93M491.22M556.81M299.66M337.54M279.95M208.27M63.47M-221.64M-35.48M-40.89M36.49M-122.9M-179.57M-65.46M54.95M40.82M15.91M19.49M-5.53M-87.76M-124.45M36.27M
FCF Growth %24.96%23.27%21.1%1.73%-7.74%-0.96%52.91%15.04%-26.73%-11.78%85.81%-11.22%20.57%34.42%228.14%128.64%-524.61%13.22%-212.06%129.69%31.56%-174.33%-219.13%34.62%156.62%-18.4%452.35%93.7%29.48%-443.16%66.35%
FCF / Revenue %73.65%73.33%67.79%61.97%65.87%59%70.95%44.58%40.82%54.08%61.81%40.3%66.87%66.86%59.43%21.72%-85.8%-17.97%-21.1%22.87%-90.69%-163.77%-75.26%67.67%33.25%6.65%7.4%-4.56%-80.28%-137.06%49.59%

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

Operator Restructuring and Regulation

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

FFO Quality Reflects Operational Resilience

As reported in quarterly financial filings, Omega’s FFO consistently exceeds GAAP net income, with the FFO-to-Net Income ratio reaching 1.43 in 2026Q1, which suggests that non-cash depreciation charges remain the primary driver of the divergence between accounting earnings and actual cash-based performance metrics.

The consistent premium of FFO over net income highlights the capital-intensive nature of the SNF portfolio, where significant depreciation masks the underlying cash-generating capacity of the assets. Investors should monitor this spread, as a narrowing gap could indicate either a reduction in asset base or a shift in the underlying accounting treatment of property impairments.

Dividend Coverage Improving Post-Restructuring

Based on the provided historical data, the dividend payout ratio relative to AFFO has improved from a strained 1.26 in 2023Q4 to 0.84 in 2026Q1, indicating that the company is successfully restoring its cash flow buffer following a period of significant operator-level financial distress.

The trend toward a more sustainable payout ratio suggests that management's strategy of pruning underperforming assets and restructuring lease terms is beginning to yield tangible cash flow benefits. While the current coverage appears adequate, the reliance on AFFO as a proxy for distributable cash requires ongoing vigilance regarding the sustainability of current rent collection levels.

Maintenance Capex Remains Historically Low

According to recent financial statements, Omega’s maintenance capital expenditures have remained minimal, often hovering near zero in recent quarters, which reflects the triple-net lease structure that effectively shifts the burden of property-level tenant improvements and leasing commissions directly onto the facility operators themselves.

This low-capex profile is a structural advantage that preserves cash flow for dividend distributions, though it may also obscure the true long-term capital needs of aging healthcare facilities. Analysts should investigate whether this lack of reported capex implies a transfer of long-term deferred maintenance risk to tenants that could eventually impact future lease renewals.

Depreciation Distorts True Earnings Power

As indicated by the historical data, the significant gap between GAAP net income and FFO underscores the extent to which non-cash depreciation charges distort the perceived profitability of the portfolio, with FFO providing a more accurate reflection of the company's ability to generate recurring cash flow.

The persistent distortion caused by depreciation highlights why GAAP metrics are insufficient for evaluating this REIT's performance. The ability to maintain FFO growth despite the volatility in net income suggests that the core business model remains resilient, provided that the underlying operator rent coverage ratios remain within manageable thresholds.

OHI — Frequently Asked Questions

Quick answers to the most common questions about buying OHI stock.

How much cash does Omega Healthcare Investors, Inc. (OHI) generate from operations?

Omega Healthcare Investors, Inc. (OHI) generated $878.6M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Omega Healthcare Investors, Inc.'s free cash flow?

Omega Healthcare Investors, Inc. (OHI) generated $878.6M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Omega Healthcare Investors, Inc.'s capital expenditure (CapEx)?

Omega Healthcare Investors, Inc. (OHI) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Omega Healthcare Investors, Inc. distribute cash to shareholders?

In 2025, Omega Healthcare Investors, Inc. (OHI) returned $780.4M to shareholders via cash dividends. This shows the company's commitment to returning capital to its equity investors.